UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens

Neuropathology and applied neurobiology, 2012-10, Vol.38 (6), p.591-601

2012

Volltextzugriff (PDF)

A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design

Molecular genetics and metabolism, 2016-11, Vol.119 (3), p.239-248

2016

Volltextzugriff (PDF)

Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy

Journal of medical genetics, 2005-02, Vol.42 (2), p.108-120

2005

Volltextzugriff (PDF)

RENT REGULATIONS AFTER CEDAR POINT

Columbia law review, 2023-03, Vol.123 (2), p.475-512

Flanigan, Abigail K.

2023

Volltextzugriff (PDF)

N-terminal alpha dystroglycan (αDG-N): A potential serum biomarker for Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S158-S158

2016

Volltextzugriff (PDF)

Note: Rent regulations after 'Cedar Point'

Columbia law review, 2023-03, Vol.123 (2), p.475-511

Abigail K Flanigan

2023

Volltextzugriff (PDF)

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis

Neuromuscular disorders : NMD, 2014-03, Vol.24 (3), p.222-226

2014

Volltextzugriff (PDF)

Reduced Hedgehog signalling in Duchenne muscular dystrophy impairs muscle regeneration and function

Neuromuscular disorders : NMD, 2017-03, Vol.27, p.S13-S13

2017

Volltextzugriff (PDF)

Validity of ACTIVE for use across ambulatory abilities in Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S229-S230

2015

Volltextzugriff (PDF)

Evaluating the effect of a monetary incentive on performance of the 100-meter timed test in Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S186-S187

2016

Volltextzugriff (PDF)

Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance

Human mutation, 2008-06, Vol.29 (6), p.809-822

2008

Volltextzugriff (PDF)

Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy

Journal of comparative effectiveness research, 2020-10, Vol.9 (14), p.973-984

2020

Volltextzugriff (PDF)

A single neonatal delivery of an exon 2 directed AAV9.U7snRNA vector results in long-term dystrophin expression that prevents pathologic features in the Dup2 mouse

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S126-S127

2016

Volltextzugriff (PDF)

Duplications in the DMD gene

Human mutation, 2006-09, Vol.27 (9), p.938-945

2006

Volltextzugriff (PDF)

Neurology Academic Advisory Committee: a strategy for faculty retention and advancement

Neurology, 2011-08, Vol.77 (7), p.684-690

2011

Volltextzugriff (PDF)

302P Dystrophin quantification by capillary western immunoassay and western blot across the dystrophinopathy spectrum

Neuromuscular disorders : NMD, 2024-10, Vol.43, p.104441, Article 104441.497

2024

Volltextzugriff (PDF)

Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24

Neurology, 1999-10, Vol.53 (6), p.1180-1180

1999

Volltextzugriff (PDF)

G.P.357 - Early expression of ΔCH1 dystrophin isoform reverses or prevents muscular dystrophy in the Dup2 mouse

Neuromuscular disorders : NMD, 2015, Vol.25, p.S292-S293

2015

Volltextzugriff (PDF)

A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations

Neuromuscular disorders : NMD, 2006-10, Vol.16 (9), p.571-582

2006

Volltextzugriff (PDF)

A Review of School-Based Interventions to Reduce Stigma towards Schizophrenia

Psychiatric quarterly, 2020-12, Vol.91 (4), p.983-1002

2020

Volltextzugriff (PDF)

Early expression of ΔCH1 dystrophin isoform reverses or prevents muscular dystrophy in the Dup2 mouse

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S292-S293

2015

Volltextzugriff (PDF)

Rapid Direct Sequence Analysis of the Dystrophin Gene

American journal of human genetics, 2003-04, Vol.72 (4), p.931-939

2003

Volltextzugriff (PDF)

G.P.96

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.823-824

2014

Volltextzugriff (PDF)

HT-100: Interim safety, pharmacokinetics, and pharmacodynamic data in DMD boys

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S263

2015

Volltextzugriff (PDF)

435P Correction of a common Duchenne muscular dystrophy mutation by CRISPR/Cas9 gene editing using homology-independent targeted integration

Neuromuscular disorders : NMD, 2024-10, Vol.43, p.104441, Article 104441.306

2024

Volltextzugriff (PDF)

1 – 25 von 756

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(690)
Mit Volltextzugriff
(593)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(12)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens

A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design

Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy

RENT REGULATIONS AFTER CEDAR POINT

N-terminal alpha dystroglycan (αDG-N): A potential serum biomarker for Duchenne muscular dystrophy

Note: Rent regulations after 'Cedar Point'

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis

Reduced Hedgehog signalling in Duchenne muscular dystrophy impairs muscle regeneration and function

Validity of ACTIVE for use across ambulatory abilities in Duchenne muscular dystrophy

Evaluating the effect of a monetary incentive on performance of the 100-meter timed test in Duchenne muscular dystrophy

Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance

Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy

A single neonatal delivery of an exon 2 directed AAV9.U7snRNA vector results in long-term dystrophin expression that prevents pathologic features in the Dup2 mouse

Duplications in the DMD gene

Neurology Academic Advisory Committee: a strategy for faculty retention and advancement

302P Dystrophin quantification by capillary western immunoassay and western blot across the dystrophinopathy spectrum

Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24

G.P.357 - Early expression of ΔCH1 dystrophin isoform reverses or prevents muscular dystrophy in the Dup2 mouse

A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations

A Review of School-Based Interventions to Reduce Stigma towards Schizophrenia

Early expression of ΔCH1 dystrophin isoform reverses or prevents muscular dystrophy in the Dup2 mouse

Rapid Direct Sequence Analysis of the Dystrophin Gene

G.P.96

HT-100: Interim safety, pharmacokinetics, and pharmacodynamic data in DMD boys

435P Correction of a common Duchenne muscular dystrophy mutation by CRISPR/Cas9 gene editing using homology-independent targeted integration

Suchergebnisse filtern